All in all, LECT2 may mediate the progression of NAFLD by promoting liver lipid accumulation and inflammation as well as IR through STAT-1 signaling pathway, which might provide new insights into the diagnosis and treatment of NAFLD. Here, STAT1 is linked to metabolic dysfunction-associated steatotic liver disease.